← 治験一覧に戻る
脳腫瘍患者における放射線療法と併用したAZD1390の安全性と忍容性を評価する研究
基本情報
- NCT ID
- NCT03423628
- ステータス
- 募集中
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 180
- 治験依頼者名
- AstraZeneca
概要
This study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors. This is the first time AZD1390 is being given to patients. This study will test safety, tolerability and PK (how the drug is absorbed, distributed and eliminated) of ascending doses of AZD1390 in combination with distinct regimens of radiation therapy
対象疾患
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, MalignantLeptomeningeal Disease (LMD)
介入
Radiation Therapy(RADIATION)
AZD1390(DRUG)
Radiation Therapy(RADIATION)
Radiation Therapy(RADIATION)
AZD1390(DRUG)
AZD1390(DRUG)
依頼者（Sponsor）
アストラゼネカ株式会社(INDUSTRY)